Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
They are not, on their own, a weight-loss treatment
To meet this need, investigators launched the Semaglutide Treatment Effect in People with obesity (STEP) program of phase 3 clinical trials to assess the safety and efficacy of a weekly 2.4-mg subcutaneous injection of semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA)
Federal law does not automatically require a prescription for standalone purchases
Pediatr Clin North Am
US$ 20.64
US$ 27.85
US$ 26.25
US$ 28.54
)
US$ 29.62
US$ 27.60
